Literature DB >> 20842828

[Usefulness of evaluation of soluble fragment cytokeratin 18, carcinoembryonic antigen and gastrointestinal carcinoma-associated antigen in diagnostic of patients with colorectal cancer].

Robert Partyka1, Artur Sandelewski, Iwona Łobejko, Jacek Kocot, Przemysław Jałowiecki, Danuta Kokocińska.   

Abstract

Colorectal cancer is one of the most frequent malignant neoplasms which affects humans. Last year studies indicate a constantly increasing inception rate. Multidisciplinary teams direct all their efforts towards detection of cancer in it's asymptomatic phase. In parallel with development of diagnostic imaging is development of clinical immunodiagnostics. The last allows for quantitative determination of active neoplasmic process markers. In the following article authors show the most frequent markers used in immunodiagnostic. Colorectal cancer known as "tumor burden markers CEA, CA 19-9 as well as the "new one" tissue polypeptide specific antigen proliferation marker--TPS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842828

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  3 in total

1.  Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer.

Authors:  Jing Jia; MinZhe Li; Wenhao Teng; Lin Wang; Weidong Zang; Jun Xiao; Ying Chen
Journal:  J Oncol       Date:  2021-12-27       Impact factor: 4.375

Review 2.  The diagnostics of colorectal cancer.

Authors:  Magdalena Swiderska; Barbara Choromańska; Ewelina Dąbrowska; Emilia Konarzewska-Duchnowska; Katarzyna Choromańska; Grzegorz Szczurko; Piotr Myśliwiec; Jacek Dadan; Jerzy Robert Ladny; Krzysztof Zwierz
Journal:  Contemp Oncol (Pozn)       Date:  2013-12-20

3.  Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.

Authors:  Peng Wang; Chun Li; Fan Zhang; Xuzhe Ma; Xiaodong Gai
Journal:  Dis Markers       Date:  2018-09-27       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.